Actuated Medical, Inc.

Actuated Medical develops patented platform technologies for minimally-invasive brain access, implant insertion, and therapeutic delivery. The company specializes in two primary product lines: the NeuralGlider Inserter, which uses micro-oscillation technology to insert brain implants with improved precision and reduced tissue trauma, enhancing implant performance and longevity; and the NeuralGlider Injector, which enables targeted drug delivery deep into the brain using finer, less-invasive needles to minimize tissue damage and medication loss. These technologies serve partners developing deep brain stimulation (DBS), neurological implants, and intracranial drug therapies for conditions including Parkinson's disease, epilepsy, treatment-resistant neurological disorders, brain cancer, AAV gene therapy, and addiction treatments. Actuated Medical positions itself as a foundational platform provider that collaborates with leading innovators in neurotechnology and brain therapeutics. The company has demonstrated significant scientific traction through peer-reviewed publications and preclinical validation studies. Their technology addresses critical clinical needs in neurological treatment where precise brain access and minimal tissue trauma directly impact patient outcomes and long-term implant efficacy.